Jennifer Hinkel

DPhil Research

My DPhil research in Evidence Based Health Care at the University of Oxford is supervised by Dr. Carl Heneghan and Dr. Clare Bankhead at Oxford's Centre for Evidence Based Medicine (CEBM). 

Recent Publications, Abstracts, and Presented Papers

Hinkel JM, Gorman T, Brar SS, Ray A. Developing a real-world outcomes forecast model using matched oncology clinical trials and real world evidence to inform policy-making and reimbursement approaches. Proffered Paper, European Society for Medical Oncology, September 2020.

Hinkel JM, Brar SS, Ray A. A Conceptual Framework for Valuation and Utility of Non-Clinical Outcomes. Virtual Poster Presentation, International Society for Pharmacoeconomic and Outcomes Research, May 2020.

Conway M, Malandrucco D, Hinkel JM. Modeling Geographic Barriers to Ovarian Cancer Clinical Trials in Pennsylvania. Pennsylvania Geographer 2019; 57 (2): 16-31.

Hinkel JM, Brar SS, Lalmalani RJ, et al. Proposing and evaluating a design for GDPR-compliant, scalable technology for automatic adjudication of risk-sharing agreements. Value in Health. 2019;22:S769.

Hinkel JM, Ray A, Brar S, et al. Modeling an oncology outcomes-based contract using a blockchain database approach: Cost and technology considerations. J Clin Oncol 2019;37:e18360–e18360.

Fonseca R et al. Cost vs. Value and the Price of Innovation in Cancer Care. Goldwater Inst. 2018. Epub.

Hinkel J, Dean B, McGivney WT. Evaluating a Conceptual Platform for Facilitating and Scaling Pharmaceutical Risk Sharing Agreements. Poster Presentation, ISPOR 21st Annual International Meeting. May 2018.

Hinkel JM, Sexton DB. Exploring cancer survivor perspectives on the value of life and time post-diagnosis. Poster Presentation, ISPOR 22nd Annual International Meeting. May 2017. Abstract PCN164.

Hinkel JM, Sexton DB, Egan-Kunicki J. Value of life and time: A survivorship perspective. J. Clin. Oncology 2017 35:15_supple, e18298.

Hinkel JM, Sexton D, McGivney WT. Forecasting Financial Impact of Alternative Payment Models to Cancer Drug Manufacturers. J. Clin. Oncology 2017 ASCO Ann Mtg Proceedings. 35 (15): 6549.

Lyle JL, Vandergrift JL, Hinkel, JM, Lepisto EM, Cortazzo KA, Sherman S, Stewart FM. Influential Factors for Post-Fellowship Career Decision-Making: An NCCN Survey. J. Natl Compr Canc Netw. 2012;10:969-974.

Hinkel JM, Li EC, Sherman SL. Insights and perspectives in the clinical and operational management of cancer-related anemia. J. Natl Compr Canc Netw. 2010 Sep;8 Suppl 7:S38-55

 Schwartz RN, Eng KJ, Frieze DA, Gosselin TK, Griffith N, Seung AH, Hinkel JM, Johnson PE, Johnson SA, Li EC, Szabatura AH, Wong MK. NCCN Task Force Report: Specialty Pharmacy. J. Natl Compr Canc Netw. 2010 Jul;8 Suppl 4:S1-12.

Hinkel JM, Vandergrift JL, Perkel SJ, Waldinger MB, Levy W, Stewart FM. Practice and productivity of physician assistants and nurse practitioners in outpatient oncology clinics at national comprehensive cancer network institutions. J. Oncol Pract. 2010 Jul;6(4):182-7. Epub 2010 Jun 23

Hinkel JM, Vandergrift JL, Lepisto EM, Minogue KA, Stewart FM. Fellowship characteristics associated with fellows’ interest in pursuing clinical research: A NCCN survey. J. Clin. Oncology 2010 ASCO Ann Mtg Proceedings. 28 (15): 6157.

Li EC, Hinkel JM, Gallagher L, DeVader SR, Vandergrift JL, Lepisto EM. NCCN Chemotherapy Order Templates: Enhancing patient safety through standardization. Amer. Soc. of Clin. Oncology 2009. Published Abstract.

Hinkel JM, Vandergrift JL, Perkel SJ, Waldinger MB, Levy W, Stewart FM. The impact of mid-level providers on productivity in outpatient oncology clinics at National Comprehensive Cancer Network (NCCN) institutions. Amer. Soc. of Clin. Oncology 2009.

Hinkel JM. Addressing issues in patient safety. J. Natl Compr Canc Netw. 2007 Apr; 5(4):360-2

Patents and Patent Applications

Hinkel JM. Method and system for authenticating and monitoring home health interactions. U.S. Patent 9,703,931 filed June 6, 2012 and issued July 11, 2017, and U.S. Patent 10,607,731, filed June 6, 2017, and issued March 31, 2020.

Hinkel JM, Ray A. Systems and methods of generating, validating, approving, recording, and utilizing digital data assets in a blockchain platform using a transactional proof of work. U.S. Patent Application, Publication Number 20190318350, filed April 12, 2019.

Speaking Engagements and Presentations

"The Value of Innovation", Keynote address, Mayo Clinic Phoenix Continuing Education Weekend. February 2020.

"Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage", panelist, BIO International Convention. June 2020.

Biobrief

Jennifer Hinkel is a researcher and business leader in oncology outcomes, data, and health economics. Currently, she is VP for Strategic Collaborations at Caris Life Sciences, a DPhil research student in Evidence Based Health Care at the University of Oxford, and on the Board of Lydion Research, a data economics science company. She also mentors a number of health and technology early-stage companies and founders. Her past roles include as a Senior Partner in a boutique market access consultancy as well as strategic, analytic, and commercial roles at Roche and Genentech in the US, Latin America, and Europe. Prior to entering the life sciences industry, Hinkel held roles in the non-profit and public sector including at National Comprehensive Cancer Network (NCCN), the Association for State and Territorial Health Officials (ASTHO), and as a researcher for a member of the House of Lords, UK Parliament. Ms. Hinkel holds degrees from the Georgia Institute of Technology (BS International Affairs) and the London School of Economics (MSc International Health Policy). She has lectured in Health Systems and Health Economics at Penn State University and Arcadia University, holds patents in health care technology, and has published numerous articles and abstracts related to market access and oncology health services research. As a survivor of Stage III Hodgkin Lymphoma, Ms. Hinkel has a special interest in oncology innovation. To support the broader survivor and oncology community, Ms. Hinkel founded Resilience Racing, the first all-cancer-survivor sailing team, and also launched the 40 Under 40 in Cancer annual awards program.

Other Projects & Interests

I compose for musical theater. Here is an example of my latest work-in-progress, Adulting for Beginners, produced as part of a workshop sponsored by the San Francisco Bay Play Café and Musical Café.

I'm an avid sailor and founder of Resilience Racing, the cancer survivor sailing team.

Essays and Blogs

Cancer, Sailing, and Living to the Limit

Stretch, Bounce, Grow: A New Paradigm for Resilience

A Survivor’s Take on Cancer Drugs and the “Moonshot”

Having Cancer Doesn’t Make Me Worth Less

Life, Death, and Money: The Hidden Economics of Cancer

Whose Data Is It, Anyway?